Replies to post #560505 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

It's clearly relevant as NWBO stated that the trial was confounded by the crossover with patients being given multiple doses of NWBO.

NWBO reported it multiple 10Ks and they were very specific about the issues with the trial.